For instance, in triple adverse breast cancer (TNBC),25 As well as in hepatocellular carcinoma,26 DNA methylation profiles have helped on the identification of distinct subgroups with clinical relevance. Epigenetic strategies have also served to the event of prognostic exams to assess the sensitivity of cancer cells to certain medicines.27 https://directivepublications.org/world-journal-of-clinical-cancer-research/